[Value of beta-blockers in the treatment of idiopathic intracranial hypertension (physiopathogenetic basis)].
We report three clinical cases of idiopathic intracranial hypertension with favorable evolution. The treatment of this poorly-understood affection is still only symptomatic. Through the literature, we review the different physiopathological hypotheses proposed, among which the faultly resorption of C S F predominates. By analogy with the physiopathogenesis of primary open-angle glaucoma, we have treated these patients with beta-blocking agents.
D000328:Adult; D001082:Aqueous Humor / Q000502:physiology; D002831:Choroid Plexus / Q000187:drug effects; D005260:Female; D005902:Glaucoma, Open-Angle / Q000503:physiopathology; D006261:Headache / Q000628:therapy; D006801:Humans; D007427:Intracranial Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010211:Papilledema / Q000628:therapy; D011559:Pseudotumor Cerebri / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000503:physiopathology; D013999:Timolol / Q000627:therapeutic use*
D013999:Timolol
Intérêt des béta-bloquants dans le traitement de l'hypertension intra-crânienne idiopathique (base physiopathogénique).